NLRC3 and Autoimmunity: Uchimura et al. revealed that NLRC3 functioned as a negative regulator affecting the proliferation of both Th1 and Th17 cells, limiting IFN-γ and TNF expression by CD4+ T cells and restricting autoimmunity by attenuating T cell signaling and metabolic pathways [70].